Search

Your search keyword '"Zuurbier, C.J."' showing total 48 results

Search Constraints

Start Over You searched for: Author "Zuurbier, C.J." Remove constraint Author: "Zuurbier, C.J."
48 results on '"Zuurbier, C.J."'

Search Results

1. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+](c)/ROS-pathway in human endothelial cells

2. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Catalog

Books, media, physical & digital resources

5. Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress

6. Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling

7. The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury

8. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

9. Quantification of Myocardial Creatine and Triglyceride Content in the Human Heart: Precision and Accuracy of in vivo Proton Magnetic Resonance Spectroscopy.

13. Effect of hyperglycaemia and diabetes on acute myocardial ischaemia–reperfusion injury and cardioprotection by ischaemic conditioning protocols

14. SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models

15. Cardiac metabolism as a driver and therapeutic target of myocardial infarction

16. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations

20. Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart

21. Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial

22. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: Mitochondrial inhibition as driver of cardiac failure?

23. In vivo mouse myocardial P-31 MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations

25. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling

26. Reduced hexokinase II impairs muscle function 2 weeks after ischemia-reperfusion through increased cell necrosis and fibrosis

27. Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice

28. In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique

36. Inhibition of the pentose phosphate pathway decreases ischemia–reperfusion-induced creatine kinase release in the heart

37. Functional heterogeneity of oxygen supply-consumption ratio in the heart.

41. Therapy and mechanisms of cardiac ischemia-reperfusion injury

42. Direct cardiac and endothelial effects of sodium/glucose cotransporter 2 inhibitors and the role of the sodium/hydrogen exchanger 1

43. Inflammation and acute myocardial ischemia-reperfusion injury using a closed-chest mouse model

44. Mitochondrial hexokinase and ischemic sensitivity and metabolism of the heart

45. Organ protection by the noble gas helium

46. Myocardial microcirculation and mitochondrial energetics in the isolated rat heart

47. The role of mitochondrial hexokinase II in ischemia-reperfusion damage

48. Measuring microvascular and mitochondrial oxygen tension: novel techniques for studying tissue oxygenation